1. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986): Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology25: 563–576.
2. Peroutka SJ, Snyder SH (1979): Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H] spiroperidol. Mol Pharmacol16: 687–699.
3. Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981): Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sciences28: 1015–1022.
4. Feniuk W, Hare J, Humphrey PPA (1981): An analysis of the mechanism of 5-hydroxytryptamine-induced vasopressor responses in ganglion-blocked anaesthetized dogs. J Pharm Pharmacol33: 155–160.
5. Colpaert FC, Niemegeers CJE, Janssen PAJ (1982): A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther221: 206–214.